Autosomal Dominant Leukodystrophy Caused by Lamin B1 Duplications: A Clinical and Molecular Case Study of Altered Nuclear Function and Disease

被引:26
|
作者
Padiath, Quasar Saleem [1 ,2 ]
Fu, Ying-Hui [1 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA
[2] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA
来源
NUCLEAR MECHANICS AND GENOME REGULATION | 2010年 / 98卷
关键词
PROGRESSIVE MULTIPLE-SCLEROSIS; PELIZAEUS-MERZBACHER-DISEASE; ADULT-ONSET LEUKODYSTROPHY; GILFORD-PROGERIA-SYNDROME; AUTONOMIC SYMPTOMS; OLIGODENDROCYTE DEVELOPMENT; STRUCTURAL ORGANIZATION; PARTIAL LIPODYSTROPHY; ALEXANDER-DISEASE; A-TYPE;
D O I
10.1016/S0091-679X(10)98014-X
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Autosomal dominant leukodystrophy (ADLD) is an adult-onset demyelinating disorder that has recently shown to be caused by duplications of the nuclear lamina gene, lamin B1. This chapter attempts to collate and summarize the current knowledge about the disease and the clinical, pathological, and radiological presentations of the different ADLD families described till date. It also provides an overview of the molecular genetics underlying the disease and the mechanisms that may cause the duplication mutation event. ADLD is the first disease that has ever been linked to lamin B1 mutations and it expands the pathological role of the nuclear lamia to include disorders of the brain. The chapter also speculates on the different mechanisms that may link an important and ubiquitous structure like the nuclear lamina with the complex and cell-specific functions of myelin formation and maintenance. Understanding these mechanisms may not only prove helpful in understanding ADLD pathology but can also help in identifying new pathways that may be involved in myelin biology that can have implications for common demyelinating diseases like multiple sclerosis.
引用
收藏
页码:337 / 357
页数:21
相关论文
共 44 条
  • [21] An LMNB1 Duplication Caused Adult-Onset Autosomal Dominant Leukodystrophy in Chinese Family: Clinical Manifestations, Neuroradiology and Genetic Diagnosis
    Dai, Yi
    Ma, Yaling
    Li, Shengde
    Banerjee, Santasree
    Liang, Shengran
    Liu, Qing
    Yang, Yinchang
    Peng, Bin
    Cui, Liying
    Jin, Liri
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2017, 10
  • [22] Lamin B1 and nuclear morphology in peripheral cells as new potential biomarkers to follow treatment response in Huntington's disease
    Garcia-Forn, Marta
    Castany-Pladevall, Carla
    Golbano, Arantxa
    Perez-Perez, Jesus
    Brito, Veronica
    Kulisevsky, Jaime
    Perez-Navarro, Esther
    CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (02):
  • [23] Clinical and histological findings of autosomal dominant renal-limited disease with LMX1B mutation
    Konomoto, Takao
    Imamura, Hideaki
    Orita, Mayuko
    Tanaka, Etsuko
    Moritake, Hiroshi
    Sato, Yuji
    Fujimoto, Shouichi
    Harita, Yutaka
    Hisano, Satoshi
    Yoshiura, Koh-ichiro
    Nunoi, Hiroyuki
    NEPHROLOGY, 2016, 21 (09) : 765 - 773
  • [24] Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease The DIPAK 1 Randomized Clinical Trial
    Meijer, Esther
    Visser, Folkert W.
    van Aerts, Rene M. M.
    Blijdorp, Charles J.
    Casteleijn, Niek F.
    D'Agnolo, Hedwig M. A.
    Dekker, Shosha E. I.
    Drenth, Joost P. H.
    de Fijter, JohanW.
    van Gastel, Maatje D. A.
    Gevers, Tomj J.
    Lantinga, Marten A.
    Losekoot, Monique
    Messchendorp, A. Lianne
    Neijenhuis, Myrte K.
    Pena, Michelle J.
    Peters, Dorien J. M.
    Salih, Mahdi
    Soonawala, Darius
    Spithoven, Edwin M.
    Wetzels, Jack F.
    Zietse, Robert
    Gansevoort, Ron T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (19): : 2010 - 2019
  • [25] Autosomal dominant optic atrophy related to OPA1 gene mutation: a clinical and molecular study of 14 families
    Rosini, F.
    Gallus, G. N.
    Pretegiani, E.
    Serchi, V.
    Tumminelli, G.
    Piu, P.
    Cardaioli, E.
    Da Pozzo, P.
    Marzoli, S. Bianchi
    Collura, M.
    Franceschini, R.
    Dotti, M. T.
    Federico, A.
    Rufa, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 81 - 81
  • [26] Autosomal-dominant medullary cystic kidney disease type 1: Clinical and molecular findings in six large Cypriot families
    Stavrou, C
    Koptides, M
    Tombazos, C
    Psara, E
    Patsias, C
    Zouvani, I
    Kyriacou, K
    Hildebrandt, F
    Christofides, T
    Pierides, A
    Deltas, CC
    KIDNEY INTERNATIONAL, 2002, 62 (04) : 1385 - 1394
  • [27] A Case of Severe Aortic Valve Regurgitation Caused by an Ascending Aortic Aneurysm in a Young Patient With Autosomal Dominant Polycystic Kidney Disease and Normal Renal Function
    Kim, Jeongeun
    Kim, Sang Min
    Lee, Sang Yeub
    Lee, Ho-Chang
    Bae, Jang-Whan
    Hwang, Kyung-Kuk
    Kim, Dong-Woon
    Cho, Myeong-Chan
    Byeon, Sun-Ju
    Kim, Ki-Bong
    KOREAN CIRCULATION JOURNAL, 2012, 42 (02) : 136 - 139
  • [28] Autosomal dominant Best disease with an unusual electrooculographic light rise and risk of angle-closure glaucoma: a clinical and molecular genetic study
    Low, Sancy
    Davidson, Alice E.
    Holder, Graham E.
    Hogg, Chris R.
    Bhattacharya, Shomi S.
    Black, Graeme C.
    Foster, Paul J.
    Webster, Andrew R.
    MOLECULAR VISION, 2011, 17 (247): : 2272 - 2282
  • [29] A case of hereditary angioedema with early clinical manifestations of the disease caused by heterozygote non-dominant SERPING1 variant
    Guryanova, Irina
    Polyakova, Ekaterina
    Liubushkin, Aliaksandr
    Skapavets, Katsiaryna
    Aleshkevich, Svetlana
    Belevtsev, Mikhail
    JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (SUPPL 1) : S29 - S29
  • [30] Autosomal Dominant Tubulointerstitial Kidney Disease HNF1B with Maturity-Onset Diabetes of the Young: A Case Report With Kidney Biopsy
    Oba, Yuki
    Sawa, Naoki
    Mizuno, Hiroki
    Hoshino, Junichi
    Kinowaki, Keiichi
    Ohashi, Kenichi
    Morisada, Naoya
    Iijima, Kazumoto
    Yamaguchi, Yutaka
    Ubara, Yoshifumi
    KIDNEY MEDICINE, 2021, 3 (02) : 278 - 281